<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35442761</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-9102</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of speech, language, and hearing research : JSLHR</Title><ISOAbbreviation>J Speech Lang Hear Res</ISOAbbreviation></Journal><ArticleTitle>Minimally Detectable Change of Speech Intelligibility in Speakers With Multiple Sclerosis and Parkinson's Disease.</ArticleTitle><Pagination><StartPage>1858</StartPage><EndPage>1866</EndPage><MedlinePgn>1858-1866</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1044/2022_JSLHR-21-00648</ELocationID><Abstract><AbstractText Label="PURPOSE">This study sought to determine the minimally detectable change (MDC) of sentence intelligibility for speakers with multiple sclerosis (MS) and Parkinson's disease (PD).</AbstractText><AbstractText Label="METHOD">Speakers included 78 participants consisting of 32 neurologically healthy control speakers, 30 speakers with MS, and 16 speakers with PD. All speakers were recorded reading 11 sentences comprising the Speech Intelligibility Test (SIT), which were subsequently transcribed by inexperienced listeners. Percent correct scores were calculated for each sentence. An average percent correct score was also calculated for each speaker. The MDC at the 95% confidence interval was calculated using the following formula: MDC<sub>95</sub> = 1.96 &#xd7; &#x221a;2 &#xd7; standard error of measurement. Speakers were divided into operationally defined categories of severity, and MDCs were calculated for each category to permit comparison to MDCs reported for speakers with amyotrophic lateral sclerosis (ALS). Kruskal-Wallis tests were conducted to compare MDCs between groups and severity categories.</AbstractText><AbstractText Label="RESULTS">The average MDC<sub>95</sub> for control speakers was 5.53% (range = 3.21%-7.47%) and was statistically smaller than MDCs for speakers with MS (average = 10.08%, range = 5.30%-15.62%) and those for speakers with PD (average = 10.98%, range = 8.60%-13.98%). Statistical analyses further revealed significant differences between MDCs across severity categories.</AbstractText><AbstractText Label="CONCLUSIONS">In agreement with previous work in ALS conducted under similar conditions (i.e., orthographic transcription of SIT sentences in a quiet listening environment), the MDC<sub>95</sub> of speech intelligibility ranged from 3% to 10% for speakers with MS and PD who have mildly impaired speech. These estimates are a step toward the development of a universal language with which to evaluate speech changes in a variety of patient populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stipancic</LastName><ForeName>Kaila L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0001-5185-563X</Identifier><AffiliationInfo><Affiliation>Department of Communicative Disorders and Sciences, University at Buffalo, The State University of New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tjaden</LastName><ForeName>Kris</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0971-7449</Identifier><AffiliationInfo><Affiliation>Department of Communicative Disorders and Sciences, University at Buffalo, The State University of New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DC004689</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Speech Lang Hear Res</MedlineTA><NlmUniqueID>9705610</NlmUniqueID><ISSNLinking>1092-4388</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004401" MajorTopicYN="N">Dysarthria</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013061" MajorTopicYN="N">Speech Acoustics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013065" MajorTopicYN="N">Speech Intelligibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013068" MajorTopicYN="N">Speech Production Measurement</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35442761</ArticleId><ArticleId IdType="pmc">PMC9559772</ArticleId><ArticleId IdType="doi">10.1044/2022_JSLHR-21-00648</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barnett, C. , Green, J. R. , Marzouqah, R. , Stipancic, K. L. , Berry, J. D. , Korngut, L. , Genge, A. , Shoesmith, C. , Briemberg, H. , Abrahao, A. , Kalra, S. , Zinman, L. , &amp; Yunusova, Y. (2019). Reliability and validity of speech &amp; pause measures during passage reading in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(1&#x2212;2), 42&#x2013;50. https://doi.org/10.1080/21678421.2019.1697888</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7080316</ArticleId><ArticleId IdType="pubmed">32138555</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks, B. R. (2009). Managing amyotrophic lateral sclerosis: Slowing disease progression and improving patient quality of life. Annals of Neurology, 65(Suppl. 1), S17&#x2013;S23. https://doi.org/10.1002/ana.21544</Citation><ArticleIdList><ArticleId IdType="pubmed">19191306</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks, B. R. , Miller, R. G. , Swash, M. , &amp; Munsat, T. L. (2000). El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 1(5), 293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannito, M. P. , Suiter, D. M. , Beverly, D. , Chorna, L. , Wolf, T. , &amp; Pfeiffer, R. M. (2012). Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease. Journal of Voice, 26(2), 214&#x2013;219. https://doi.org/10.1016/j.jvoice.2011.08.014</Citation><ArticleIdList><ArticleId IdType="pubmed">22209057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella, D. , Lai, J. S. , Jensen, S. E. , Christodoulou, C. , Junghaenel, D. U. , Reeve, B. B. , &amp; Stone, A. A. (2016). PROMIS fatigue item bank had clinical validity across diverse chronic conditions. Journal of Clinical Epidemiology, 73, 128&#x2013;134. https://doi.org/10.1016/j.jclinepi.2015.08.037</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4902759</ArticleId><ArticleId IdType="pubmed">26939927</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bodt, M. S. , Huici, M. E. H.-D. , &amp; Van De Heyning, P. H. (2002). Intelligibility as a linear combination of dimensions in dysarthric speech. Journal of Communication Disorders, 35(3), 283&#x2013;292. https://doi.org/10.1016/S0021-9924(02)00065-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12064788</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy, J. R. (2013). Motor speech disorders: Substrates, differential diagnosis, and management (3rd ed.). Elsevier Mosby.</Citation></Reference><Reference><Citation>Holmes, R. J. , Oates, J. M. , Phyland, D. J. , &amp; Hughes, A. J. (2000). Voice characteristics in the progression of Parkinson's disease. International Journal of Language and Communication Disorders, 35(3), 407&#x2013;418. https://doi.org/10.1080/136828200410654</Citation><ArticleIdList><ArticleId IdType="pubmed">10963022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hustad, K. C. (2007). Effects of speech stimuli and dysarthria severity on intelligibility scores and listener confidence ratings for speakers with cerebral palsy. Folia Phoniatrica et Logopaedica, 59(6), 306&#x2013;317. https://doi.org/10.1159/000108337</Citation><ArticleIdList><ArticleId IdType="pubmed">17965573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, J. L. , Baylor, C. , &amp; Yorkston, K. M. (2021). Predicting communicative participation in adults across communication disorders. American Journal of Speech-Language Pathology, 30(3S), 1301&#x2013;1313. https://doi.org/10.1044/2020_AJSLP-20-00100</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8702843</ArticleId><ArticleId IdType="pubmed">33656912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent, R. D. , Weismer, G. , Kent, J. F. , &amp; Rosenbek, J. C. (1989). Toward phonetic intelligibility testing in dysarthria. Journal of Speech and Hearing Disorders, 54(4), 482&#x2013;499. https://doi.org/10.1044/jshd.5404.482</Citation><ArticleIdList><ArticleId IdType="pubmed">2811329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansford, K. L. , Liss, J. M. , &amp; Norton, R. E. (2014). Free-classification of perceptually similar speakers with dysarthria. Journal of Speech, Language, and Hearing Research, 57(6), 2051&#x2013;2064. https://doi.org/10.1044/2014_JSLHR-S-13-0177</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9589826</ArticleId><ArticleId IdType="pubmed">25057892</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks, K. L. , Verdi, A. , Toles, L. E. , Stipancic, K. L. , Ortiz, A. J. , Hillman, R. E. , &amp; Mehta, D. D. (2021). Psychometric analysis of an ecological vocal effort scale in individuals with and without vocal hyperfunction during activities of daily living. American Journal of Speech-Language Pathology, 30(6), 2589&#x2013;2604. https://doi.org/10.1044/2021_AJSLP-21-00111</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132024</ArticleId><ArticleId IdType="pubmed">34665647</ArticleId></ArticleIdList></Reference><Reference><Citation>Milenkovic, P. (2005). TF32 [Software program] . University of Wisconsin-Madison.</Citation></Reference><Reference><Citation>Miller, N. , Noble, E. , Jones, D. , &amp; Burn, D. (2006). Life with communication changes in Parkinson's disease. Age and Ageing, 35(3), 235&#x2013;239. https://doi.org/10.1093/ageing/afj053</Citation><ArticleIdList><ArticleId IdType="pubmed">16540492</ArticleId></ArticleIdList></Reference><Reference><Citation>Noffs, G. , Perera, T. , Kolbe, S. C. , Shanahan, C. J. , Boonstra, F. M. C. , Evans, A. , Butzkueven, H. , van der Walt, A. , &amp; Vogel, A. P. (2018). What speech can tell us: A systematic review of dysarthria characteristics in multiple sclerosis. Autoimmunity Reviews, 17(12), 1202&#x2013;1209. https://doi.org/10.1016/j.autrev.2018.06.010</Citation><ArticleIdList><ArticleId IdType="pubmed">30316992</ArticleId></ArticleIdList></Reference><Reference><Citation>Patejdl, R. , &amp; Zettl, U. K. (2017). Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions. Autoimmunity Reviews, 16(9), 925&#x2013;936. https://doi.org/10.1016/j.autrev.2017.07.004</Citation><ArticleIdList><ArticleId IdType="pubmed">28698092</ArticleId></ArticleIdList></Reference><Reference><Citation>Piacentini, V. , Mauri, I. , Cattaneo, D. , Gilardone, M. , Montesano, A. , &amp; Schindler, A. (2014). Relationship between quality of life and dysarthria in patients with multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 95(11), 2047&#x2013;2054. https://doi.org/10.1016/j.apmr.2014.04.023</Citation><ArticleIdList><ArticleId IdType="pubmed">24835754</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe, W. , Seppi, K. , Tanner, C. M. , Halliday, G. M. , Brundin, P. , Volkmann, J. , Schrag, A. E. , &amp; Lang, A. E. (2017). Parkinson disease. Nature Reviews Disease Primers, 3(1), 1&#x2013;21. https://doi.org/10.1038/nrdp.2017.13</Citation><ArticleIdList><ArticleId IdType="pubmed">28332488</ArticleId></ArticleIdList></Reference><Reference><Citation>R Development Core Team. (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing.</Citation></Reference><Reference><Citation>Revicki, D. , Hays, R. D. , Cella, D. , &amp; Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102&#x2013;109. https://doi.org/10.1016/j.jclinepi.2007.03.012</Citation><ArticleIdList><ArticleId IdType="pubmed">18177782</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddle, D. , &amp; Stratford, P. (2013). Is this change real? Interpreting patient outcomes in physical therapy. F. A. Davis Company.</Citation></Reference><Reference><Citation>Sapir, S. (2014). Multiple factors are involved in the dysarthria associated with Parkinson's disease: A review with implications for clinical practice and research. Journal of Speech, Language, and Hearing Research, 57(4), 1330&#x2013;1343. https://doi.org/10.1044/2014_JSLHR-S-13-0039</Citation><ArticleIdList><ArticleId IdType="pubmed">24686571</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffen, T. , &amp; Seney, M. (2008). Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Physical Therapy, 88(6), 733&#x2013;746. https://doi.org/10.2522/ptj.20070214</Citation><ArticleIdList><ArticleId IdType="pubmed">18356292</ArticleId></ArticleIdList></Reference><Reference><Citation>Stipancic, K. L. , Palmer, K. M. , Rowe, H. P. , Yunusova, Y. , Berry, J. D. , &amp; Green, J. R. (2021). &#x201c;You say severe, I say mild&#x201d;: Toward an empirical classification of dysarthria severity. Journal of Speech, Language, and Hearing Research, 64(12), 4718&#x2013;4735. https://doi.org/10.1044/2021_JSLHR-21-00197</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9150682</ArticleId><ArticleId IdType="pubmed">34762814</ArticleId></ArticleIdList></Reference><Reference><Citation>Stipancic, K. L. , Tjaden, K. , &amp; Wilding, G. (2016). Comparison of intelligibility measures for adults with Parkinson's disease, adults with multiple sclerosis, and healthy controls. Journal of Speech, Language, and Hearing Research, 59(2), 230&#x2013;238. https://doi.org/10.1044/2015_JSLHR-S-15-0271</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4972008</ArticleId><ArticleId IdType="pubmed">26556727</ArticleId></ArticleIdList></Reference><Reference><Citation>Stipancic, K. L. , Yunusova, Y. , Berry, J. D. , &amp; Green, J. R. (2018). Minimally detectable change and minimal clinically important difference of a decline in sentence intelligibility and speaking rate for individuals with amyotrophic lateral sclerosis. Journal of Speech, Language, and Hearing Research, 61(11), 2757&#x2013;2771. https://doi.org/10.1044/2018_JSLHR-S-17-0366</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693567</ArticleId><ArticleId IdType="pubmed">30383220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sussman, J. E. , &amp; Tjaden, K. (2012). Perceptual measures of speech from individuals with Parkinson's disease and multiple sclerosis: Intelligibility and beyond. Journal of Speech, Language, and Hearing Research, 55(4), 1208&#x2013;1219. https://doi.org/10.1044/1092-4388(2011/11-0048)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5564315</ArticleId><ArticleId IdType="pubmed">22232396</ArticleId></ArticleIdList></Reference><Reference><Citation>Talman, P. , Forbes, A. , &amp; Mathers, S. (2009). Clinical phenotypes and natural progression for motor neuron disease: Analysis from an Australian database. Amyotrophic Lateral Sclerosis, 10(2), 79&#x2013;84. https://doi.org/10.1080/17482960802195871</Citation><ArticleIdList><ArticleId IdType="pubmed">18608095</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwee, C. B. , Roorda, L. D. , Dekker, J. , Bierma-Zeinstra, S. M. , Peat, G. , Jordan, K. P. , Croft, P. , &amp; de Vet, H. C. W. (2010). Mind the MIC: Large variation among populations and methods. Journal of Clinical Epidemiology, 63(5), 524&#x2013;534. https://doi.org/10.1016/j.jclinepi.2009.08.010</Citation><ArticleIdList><ArticleId IdType="pubmed">19926446</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Stan, J. H. , Maffei, M. , Masson, M. L. V. , Mehta, D. D. , Burns, J. A. , &amp; Hillman, R. E. (2017). Self-ratings of vocal status in daily life: Reliability and validity for patients with vocal hyperfunction and a normative group. American Journal of Speech-Language Pathology, 26(4), 1167&#x2013;1177. https://doi.org/10.1044/2017_AJSLP-17-0031</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5945061</ArticleId><ArticleId IdType="pubmed">29086800</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh, B. , &amp; Smith, A. (2012). Basic parameters of articulatory movements and acoustics in individuals with Parkinson's disease. Movement Disorders, 27(7), 843&#x2013;850. https://doi.org/10.1002/mds.24888</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3418799</ArticleId><ArticleId IdType="pubmed">22729986</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorkston, K. M. (2010). Management of motor speech disorders in children and adults (3rd ed.). Pro-Ed.</Citation></Reference><Reference><Citation>Yorkston, K. M. , &amp; Breukelman, D. R. (1981). Communication efficiency of dysarthric speakers as measured by sentence intelligibility and speaking rate. Journal of Speech and Hearing Disorders, 46(3), 296&#x2013;301. https://doi.org/10.1044/jshd.4603.296</Citation><ArticleIdList><ArticleId IdType="pubmed">7278175</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorkston, K. M. , &amp; Beukelman, D. (1999). Staging interventions in progressive dysarthria. SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, 9(4), 7&#x2013;12. https://doi.org/10.1044/nnsld9.4.7</Citation></Reference><Reference><Citation>Yorkston, K. M. , Beukelman, D. , &amp; Hakel, M. (2007). Speech Intelligibility Test (SIT) for Windows [Computer software] . Madonna Rehabilitation Hospital.</Citation></Reference><Reference><Citation>Yorkston, K. M. , Strand, E. A. , &amp; Kennedy, M. R. T. (1996). Comprehensibility of dysarthric Speech. American Journal of Speech-Language Pathology, 5(1), 55&#x2013;66. https://doi.org/10.1044/1058-0360.0501.55</Citation></Reference><Reference><Citation>Yuksel, E. , Unver, B. , Kalkan, S. , &amp; Karatosun, V. (2021). Reliability and minimal detectable change of the 2-minute walk test and timed up and go test in patients with total hip arthroplasty. HIP International, 31(1), 43&#x2013;49. https://doi.org/10.1177/1120700019888614</Citation><ArticleIdList><ArticleId IdType="pubmed">31928090</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova, Y. , Plowman, E. K. , Green, J. R. , Barnett, C. , &amp; Bede, P. (2019). Clinical measures of bulbar dysfunction in ALS. Frontiers in Neurology, 10, 1&#x2013;11. https://doi.org/10.3389/fneur.2019.00106</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389633</ArticleId><ArticleId IdType="pubmed">30837936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>